LINC00665 enhances tumorigenicity of endometrial carcinoma by interacting with high mobility group AT-hook 1
Authors:
Preprint
- 5 November 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Endometrial carcinoma is a frequently diagnosed cancer among females. LncRNAs are reported to be associated with various cancers. Their biological roles in endometrial carcinoma progression is an emerging scientific area. LINC00665 can exert a significant role in many cancers. However, its potential function in endometrial carcinoma is still poorly known.Method: qRT-PCR was carried out to test expression of LINC00665 and HMGA1. Western blot analysis was carried out to detect protein expression of HMGA1. Cell proliferation was evaluated using Cell Counting Kit-8 (CCK-8) and EdU assay. Flow cytometry assay was used to determine cell apoptosis and cell cycle. Wound healing and transwell invasion assay was carried out to test cell migration and invasion. Immunohistochemical staining and HE staining were conducted to assess Ki-67 and tumor growth respectively.Results: Expression of LINC00665 in clinical endometrial carcinoma tissues and cells was obviously up-regulated. Loss of LINC00665 could repress endometrial carcinoma cell viability, induce cell apoptosis and block cell cycle in G1 phase. KLE and HHUA cell migration and invasion ability were depressed by LINC00665 shRNA. Decrease of LINC00665 suppressed endometrial carcinoma tumorigenicity in vivo. RIP assay proved that LINC00665 directly bound with HMGA1 protein. shRNA of HMGA1 obviously restrained endometrial carcinoma cell growth and cell invasion.Conclusions: LINC00665 might promote endometrial carcinoma progression by positively modulating HMGA1.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- LINC00665 promotes breast cancer progression through regulation of the miR-379-5p/LIN28B axisCell Death & Disease, 2020
- LncRNA TDRG1 enhances tumorigenicity in endometrial carcinoma by binding and targeting VEGF-A proteinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- RETRACTED ARTICLE: HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancerCell Death & Disease, 2018
- LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signalingBiomedicine & Pharmacotherapy, 2016
- HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancerBiomedicine & Pharmacotherapy, 2016
- The rs6983267 SNP and long non‐coding RNA CARLo‐5 are associated with endometrial carcinomaEnvironmental and Molecular Mutagenesis, 2016
- Roles, Functions, and Mechanisms of Long Non-Coding RNAs in CancerGenomics, Proteomics & Bioinformatics, 2016
- Long Noncoding RNAs: A New Regulatory Code in Metabolic ControlTrends in Biochemical Sciences, 2015
- Associations between etiologic factors and mortality after endometrial cancer diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 trialGynecologic Oncology, 2015
- Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancerMolecular and Cellular Biochemistry, 2015